Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Operating Income (2018 - 2025)

TELA Bio has reported Operating Income over the past 8 years, most recently at $19.0 million for Q4 2025.

  • Quarterly results put Operating Income at $19.0 million for Q4 2025, up 6.85% from a year ago — trailing twelve months through Dec 2025 was -$8.1 million (down 1.6% YoY), and the annual figure for FY2025 was -$8.1 million, down 1.6%.
  • Operating Income for Q4 2025 was $19.0 million at TELA Bio, up from -$7.6 million in the prior quarter.
  • Over the last five years, Operating Income for TELA hit a ceiling of $19.0 million in Q4 2025 and a floor of -$12.3 million in Q4 2023.
  • Median Operating Income over the past 5 years was -$9.4 million (2022), compared with a mean of -$6.4 million.
  • Biggest five-year swings in Operating Income: skyrocketed 244.84% in 2024 and later plummeted 116.99% in 2025.
  • TELA Bio's Operating Income stood at -$7.7 million in 2021, then dropped by 23.32% to -$9.4 million in 2022, then tumbled by 30.08% to -$12.3 million in 2023, then skyrocketed by 244.84% to $17.8 million in 2024, then grew by 6.85% to $19.0 million in 2025.
  • The last three reported values for Operating Income were $19.0 million (Q4 2025), -$7.6 million (Q3 2025), and -$9.1 million (Q2 2025) per Business Quant data.